Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02505035 · ClinicalTrials.gov registry record · NA

Randomized Evaluation of Default Access to Palliative Services

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
34,239
Enrollment target

NCT02505035: Completed NA study, sponsored by University of Pennsylvania.

NCT02505035 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 34,239 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2340% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02505035, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
34,239 participants
Enrollment target

Study Summary

This is a large pragmatic, randomized controlled trial to test the real-world effectiveness of inpatient palliative care consultative services in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients. The investigators hypothesize that improved patient-centered outcomes can be achieved without higher costs by simply changing the default option for inpatient palliative care consultation for eligible patients from an opt-in to an opt-out system. To test this hypothesis the investigators will conduct a clinical trial at 11 hospitals using the same electronic health record within Ascension Health, the largest non-profit health system in the U.S.

Primary Outcome

The primary outcome is a composite measure of in-hospital mortality and hospital length-of-stay that ranks deaths along the length-of-stay distribution. Data is extracted from the electronic health record.

Interventions

  • BEHAVIORAL Default ordering of palliative consult

Trial Details

FieldValue
Enrollment Target 34,239 participants
Start Date 2016-03
Est. Completion 2020-09
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT02505035 record still lists

NCT02505035 is an interventional study that assigns participants to a tested intervention. Its 34,239 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2340% higher).

The record links to 0 conditions, and to 1 intervention - of which Default ordering of palliative consult is the first listed.

NCT02505035 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02505035 about?

NCT02505035 is a clinical study titled "Randomized Evaluation of Default Access to Palliative Services". This is a large pragmatic, randomized controlled trial to test the real-world effectiveness of inpatient palliative care consultative services in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients. The investigators hypothesize...

What is the current status of trial NCT02505035?

This trial is currently completed. It is a NA study. The enrollment target is 34,239 participants. The study started on 2016-03. Estimated completion is 2020-09.

What interventions are being tested in trial NCT02505035?

The interventions under investigation include: Default ordering of palliative consult (BEHAVIORAL).

Who is sponsoring clinical trial NCT02505035?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02505035's enrollment target sits among peer trials

34,239 8th of 2000 higher than 1,993 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03720613 · 34,532 participants

    Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

  • NCT02225301 · 35,000 participants · NA

    iLookOut for Child Abuse -Online Learning Module for Early Childcare Providers

  • NCT06145724 · 33,183 participants · NA

    EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)

  • NCT04477928 · 33,000 participants

    General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02505035, the US trial registry maintained by the National Library of Medicine. NCT02505035 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.